Judging by the premarket bid/ask on otc markets.com I can only assume today's posts will be filled with refuse about how NP shouldnt have said anything, he's the worst ceo etc... basically those too emotionally attached to their investment. That happens almost anytime the stock goes down. When it rockets everyone is best buds and the sky is the limit.

This PR was most likely an answer to a mountain of emails they received asking about the data. I don't know how things will turn out, but figuring that we had 87 deaths one week prior to trial completion making 22% death rate which is lower than the rate seen in rlftf placebo or dug arm, I'm comfortable with the ambiguous, yet informative PR.